548: Evaluation of elexacaftor/tezacaftor/ivacaftor on pulmonary function in cystic fibrosis patients

Autor: Hamad, A., Hiner, D., Jue, V., Shi, Y., Stoffella, S., Thakar, S., Budzik, J., Chau-Etchepare, F., Dawson, D., Gibb, E., Jahwar, S., Kamerman-Kretzmer, R., Kleinhenz, M., Ly, N., Morrissey, B., Nandalike, K., Perez, A., Yu, M.
Zdroj: In Journal of Cystic Fibrosis November 2021 20 Supplement 2:S259-S259
Databáze: ScienceDirect